Source:http://linkedlifedata.com/resource/pubmed/id/16450143
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2006-8-9
|
pubmed:abstractText |
Success of allogeneic and autologous bone marrow transplantation (BMT) is hampered by susceptibility to infection during the first two post-treatment years. Further, in treating malignant diseases, impaired anti-host reactivity for donor cells may contribute to a high rate of relapse. Both complications are a consequence of immune deficiency involving B and T lymphocytes. The present study evaluates several key parameters of the immunologic reconstitution mechanism in mice subjected to myeloablative total body irradiation following semi-allogeneic (parental) BMT. This resulted in a gradual reduction of splenic CD3, CD4 and CD8 cells until day 45 post-BMT. Concomitantly, there was an increase in monocytes and CD4+/CD8+ (double positive) cells, accompanied by a persistent elevation in the percentage of B lymphocytes. The total thymic and splenic T cell populations were reduced until day +30. The cellular reduction correlated with the poor proliferative response of the thymic and splenic cells. A decrease occurred in IL-2 mRNA expression in thymic cells during days 15-20 post-transplant, corresponding with the low level of IL-2 secretion in the spleen and thymus of the transplanted mice. In conclusion, following semi-allogeneic BMT, there was an overall immune down-regulation in the cells, gene and protein levels. Reduced immunological responsiveness following BMT reinforces the need for improving the immune dysfunction by immunotherapy post-BMT.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0340-7004
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1330-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16450143-Animals,
pubmed-meshheading:16450143-Bone Marrow Transplantation,
pubmed-meshheading:16450143-Female,
pubmed-meshheading:16450143-Gene Expression Regulation,
pubmed-meshheading:16450143-Immune System,
pubmed-meshheading:16450143-Interleukin-2,
pubmed-meshheading:16450143-Male,
pubmed-meshheading:16450143-Mice,
pubmed-meshheading:16450143-Mice, Inbred BALB C,
pubmed-meshheading:16450143-Mice, Inbred C57BL,
pubmed-meshheading:16450143-Phenotype,
pubmed-meshheading:16450143-RNA, Messenger,
pubmed-meshheading:16450143-Spleen,
pubmed-meshheading:16450143-T-Lymphocytes,
pubmed-meshheading:16450143-Thymus Gland,
pubmed-meshheading:16450143-Transplantation, Homologous
|
pubmed:year |
2006
|
pubmed:articleTitle |
Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice.
|
pubmed:affiliation |
Department of Bone Marrow Transplantation and Cancer Immunotherapy, Cell Therapy and Transplantation Research Center, Hadassah University Hospital, 91120 Jerusalem, Israel.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|